We are excited to start seeing one of our initiatives getting more press coverage. Oisin Biotechnologies and its approach to senolytics is something we are proud of. We invite you to learn more at oisinbio.com!
According to Business Insider, "a new anti-aging therapeutic in the clinical pipeline could stand to disrupt multibillion-dollar legacy franchises." Companies of importance in this field "include Unity Biotechnology, Oisin Biotechnologies, Siwa Therapeutics, and Google venture Calico."